Overview
Key stats
Fundamentals Sep 22- 52-wk high
- $13.93
- 52-wk low
- $1.87
- Prev close
- $7.68
- Mkt cap
- $6.5M
- Beta
- 2.24
- P/S
- 2.0x
- P/B
- 1.1x
- Profit margin
- -75.9%
- Op margin
- -147.1%
- ROE
- -47.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
3 funds hold a position.
Checking federal contract awards
How top traders are positioned
No data yet
No tracked top-trader positions in XBIO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No reported figure for the latest quarter.
Our data provider never published one, so there is no beat-or-miss to show. The company's own release is above where we have it.
Reports Nov 11, 2026, in 50 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -75.9%
- Market cap
- $6M
Valuation
- P/S1.99
- P/B1.07
Quality
- Operating margin-147.1%
- ROE-47.0%
- ROA-26.8%
Growth
- Beta2.24
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.